Fintel on MSN

Roivant Sciences (ROIV) price target increased by 18.98% to 32.44

The average one-year price target for Roivant Sciences (NasdaqGS:ROIV) has been revised to $32.44 / share. This is an ...
NC Biotech

Priovant advances brepocitinib toward a third Phase 3 indication in cutaneous sarcoidosis

“With the brepocitinib CS program now moving into Phase 3 alongside the dermatomyositis and non-infectious uveitis programs, Priovant continues to advance our goal of developing brepocitinib as a ...
India West

Vivek Ramaswamy Is Now A Billionaire: Forbes

WASHINGTON, DC – When billionaires are in the spotlight for their oversized influence in Washington, especially in the Trump administration, comes this news: Vivek Ramaswamy’s wealth has soared even ...
Le Lézard

Pelage Pharmaceuticals Appoints New Board Member and Expands Executive Leadership Team

Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotechnology company, today announced the appointment of Maykin Ho, Ph.D., to its board of directors, and the promotions of Nathan ...

Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction

Detailed price information for Rhythm Pharmaceuticals Inc (RYTM-Q) from The Globe and Mail including charting and trades.